Back to DE Deerfield Management Company, L.P.

XLRN

Showing 0 of 9 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in ACCELERON PHARMA INC

As of its Q3 2021 13F, Deerfield Management held 145,000 shares of XLRN (Acceleron Pharma), worth $25M. Deerfield Management listed XLRN in 8 quarterly 13F filings through Q3 2021. XLRN was 0.5% of Deerfield Management's reported 13F portfolio.

Current Value

-

Current Shares

-

Total Value Change

$0

Total Shares Change

—

No position history available for this security.

Other major holders of XLRN: T. Rowe Price Associates, Inc., FMR LLC, Avoro Capital Advisors LLC

Optional analytics helps us improve. How it’s used